By Novo Nordisk…
Novo Nordisk Pharmatech showcasing Quats range at CPhI Milan
Koege, Denmark: – World-leading insulin and quaternary ammonium compounds (Quats) specialist Novo Nordisk Pharmatech A/S will be a leading exhibitor in the Active Pharmaceutical Ingredients (API) zone of the upcoming CPhI Worldwide physical expo in Milan.
Novo Nordisk Pharmatech will exhibit from booth 18K49 in Hall 18 at the Fiera Milano exhibition center, from where it will show its world-leading range of pharmaceutical grade Quats, including Benzalkonium Chloride (BKC), Cetyl Trimethyl Ammonium Bromide (CTAB) and Cetrimide.
These Quats have a huge range of applications across life sciences and healthcare as disinfectants, decontaminants and active ingredients, as well as being important components in vaccine manufacture, in conjunction with Novo Nordisk Pharmatech’s world-renowned recombinant insulin AF.
Novo Nordisk Pharmatech will also be present as an online exhibitor in the CPhI ‘virtual’ expo digital platform that will be online through to November 19.
The strong Novo Nordisk Pharmatech team for the online and digital CPhI events will be headed by CEO Ulla Grove Krogsgaard Thomsen, supported by Global Product Manager Chantale Julien, Sales director Gernot Stadlmann, Head of Sales Timur Özbay, and Supply Chain Manager Maxim Sierra Koltomov.
“We are delighted to see CPhI Worldwide return as a face-to-face event”, commented Ulla Grove Krogsgaard Thomsen.
“This is one of the important events in our calendar for our businesses in cGMP manufactured pharmaceutical grade Quats; very valuable for networking with both existing and potential customers,” she added.
About Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S was established in 1949, acquired by Novo Nordisk in 1986 and has been part of the pharmaceutical group since then.
Novo Nordisk Pharmatech A/S is the leading worldwide supplier of recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharma and biopharmaceutical industries.
Learn more at: https://novonordiskpharmatech.com
About CPhI Worldwide 2021
Now in its 32nd year, CPhI Worldwide is the flagship European annual trade show for pharma ingredients and partner sourcing, as a one stop expo covering the entire industry, incorporating seven shows in one, also including the co-located zoned exhibitions; ICSE Outsourcing, P-MEC Machinery and Equipment, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and events and the new BioProduction.
CPhI Worldwide was last run as a physical event in 2019 in Frankfurt. The 2020 event, originally planned as a three-day event for October 2020 in Milan, Italy, was postponed due to the COVID-19 emergency Italy, and replaced by the 2020 CPhI Festival of Pharma as the world’s largest pharmaceutical virtual meeting, using online technologies to create a networking platform that will combine the world’s leading pharma companies, eminent speakers and extensive networking opportunities.
For 2021, CPhI Worldwide returns as a hybrid physical and online event, built around a three-day physical exhibition opening November 9 at the Fiera Milano exhibition center, accompanied by an online digital platform that runs from October 25 to November 19.
CPhI is organised by Informa Markets with further information at: https://www.cphi.com/europe/en/home.html
Click on Novo Nordisk Pharmatech at CPhI Online to visit home page for the event.
Click on Novo Nordisk Pharmatech A/S for video on cGMP manufacturing, pharma-grade Quats and Recombinant insulin.
Click on Link with Novo Nordisk Pharmatech to follow the company on LinkedIn.
Click on Novo Nordisk Pharmatech News for more developments at Novo Nordisk Pharmatech.